Virginia (202) 466-6937 | Arizona (602) 388-8899

Legal Events


PLEASE NOTE: THE DECISIONS PUBLISHED ON THIS WEB SITE ARE NOT AN ALL-INCLUSIVE LISTING OF ALL CASES INVOLVING EMORD AND ASSOCIATES AS COUNSEL. RESULTS DEPEND UPON A VARIETY OF FACTORS UNIQUE TO EACH CASE. THE RESULTS PUBLISHED HERE DO NOT GUARANTEE OR PREDICT A SIMILAR RESULT IN ANY FUTURE CASE UNDERTAKEN BY THE FIRM.

The following includes a representative sample of recent decisions, pleadings, and presentations.

LEGAL DECISIONS:

COMPLAINTS:

BRIEFS:

COMMENTS/PETITIONS:

  • ANH Comments in re Medicare Revisions to promote Program Efficiency (Apr. 2013)
  • CBNS Comments in re Medicare Revisions to promote Program Efficiency (Apr. 2013)
  • AbleChild.org Appeal to Connecticut Freedom of Information Commission (Apr. 2013)
  • EDA New Dietary Ingredient (NDI) Comments on FDA Guidance Document (Dec. 2011)
  • EDA New Dietary Ingredient (NDI) Comments on Economic Burden
  • FDA grants qualified claims for calcium and colon/rectal cancer and polyps
  • FDA grants qualified claims for calcium and hypertension
  • Chromium Picolinate Petition Decision
  • The Coronary Heart Disease Risk Reducing Effects of N-3 Fatty Acids
  • Connor’s Scientific References
  • Final Comments on Proposed CGMPs
  • Comments on Qualified Health Claims
  • Comments on FDA’s Task Force on Consumer Health Information for Better Nutrition
  • FTC First Amendment Petition
  • Ephedra Comments
  • First Amendment Reply Comments
  • First Amendment Comments
  • Saw Palmetto / BPH Health Claim Petition
  • B-Vitamin / Vascular Disease Health Claim Petition
  • E-Vitamin / Heart Disease Health Claim Petition
  • Comments on Proposed GMPs for Dietary Supplements
  • Comments on Proposed Ephedra Regulations
  • Petition for Rulemaking Calling on FTC to Define Competent and Reliable Scientific Evidence
  • Comments to HCFA on Privacy Regulations
  • Comments on FDA’s Significant Scientific Agreement Standard
  • Structure/Function Claims Proposed Rule

CONGRESSIONAL TESTIMONY:

FDA TESTIMONY:

COURT TRANSCRIPTS:

SPEECHES:

CONTRIBUTIONS:

Individuals and entities interested in making a financial contribution to any of our Litigation Funds should contact:

Jonathan Emord. Emord & Assiciates, P.C.,
11808 Wolf Run Lane
Clifton, VA 20124
(202-466-6937) for additional information.


Whether evaluating a concept, performing regulatory due diligence, maintaining or prosecuting regulatory filings, or contesting adverse litigation, Emord & Associates provides exceptional counsel for all your litigation and regulatory needs.

Virginia (Firm HQ)

11808 Wolf Run Lane
Clifton, VA 20124
Telephone: (202) 466-6937
Telecopier: (202) 466-6938

Arizona

2730 S. Val. Vista Dr.
Bldg. 6, Ste 133
Gilbert, AZ 85295
Telephone: (602) 388-8899
Telecopier: (602) 393-4361